Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Stefanie Gryzik"'
Autor:
Johannes Groffmann, Ines Hoppe, Wail Abbas Nasser Ahmed, Yen Hoang, Stefanie Gryzik, Andreas Radbruch, Margitta Worm, Kirsten Beyer, Ria Baumgrass
Publikováno v:
Diagnostics, Vol 14, Iss 17, p 1959 (2024)
(1) Background: The basophil activation test (BAT) is a functional whole blood-based ex vivo assay to quantify basophil activation after allergen exposure by flow cytometry. One of the most important prerequisites for the use of the BAT in the routin
Externí odkaz:
https://doaj.org/article/73d0d569fd5f40f481b11005b51786fe
Autor:
Anna Luise Grab, Peter S. Kim, Lukas John, Kamlesh Bisht, Hongfang Wang, Anja Baumann, Helgi Van de Velde, Irene Sarkar, Debarati Shome, Philipp Reichert, Calin Manta, Stefanie Gryzik, Rogier M. Reijmers, Niels Weinhold, Marc S. Raab
Publikováno v:
Cells, Vol 13, Iss 10, p 879 (2024)
Current treatment strategies for multiple myeloma (MM) are highly effective, but most patients develop relapsed/refractory disease (RRMM). The anti-CD38/CD3xCD28 trispecific antibody SAR442257 targets CD38 and CD28 on MM cells and co-stimulates CD3 a
Externí odkaz:
https://doaj.org/article/8503b9abaeac4cfa9e1744711dde30b6
Autor:
Yen Hoang, Stefanie Gryzik, Ines Hoppe, Alexander Rybak, Martin Schädlich, Isabelle Kadner, Dirk Walther, Julio Vera, Andreas Radbruch, Detlef Groth, Sabine Baumgart, Ria Baumgrass
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Recently, mass cytometry has enabled quantification of up to 50 parameters for millions of cells per sample. It remains a challenge to analyze such high-dimensional data to exploit the richness of the inherent information, even though many valuable n
Externí odkaz:
https://doaj.org/article/82ad1e16ad844b32b0a7e210d93c99e5
Autor:
Stefanie Gryzik, Yen Hoang, Timo Lischke, Elodie Mohr, Melanie Venzke, Isabelle Kadner, Josephine Poetzsch, Detlef Groth, Andreas Radbruch, Andreas Hutloff, Ria Baumgrass
Publikováno v:
eLife, Vol 9 (2020)
Dysregulated cytokine expression by T cells plays a pivotal role in the pathogenesis of autoimmune diseases. However, the identification of the corresponding pathogenic subpopulations is a challenge, since a distinction between physiological variatio
Externí odkaz:
https://doaj.org/article/b192ba23600248ffb4e36f9abad57946
Autor:
Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders, Karolin Stumpf, Cecilia Reyneri, Barbara Betz, Maike Janssen, Rabia Shahswar, Elisa Donato, Darja Karpova, Vera Thiel, Julia M. Unglaub, Susanna Grabowski, Stefanie Gryzik, Lisa Vierbaum, Richard F. Schlenk, Christoph Röllig, Michael Hundemer, Caroline Pabst, Michael Heuser, Simon Raffel, Carsten Müller-Tidow, Tim Sauer, Andreas Trumpp
Publikováno v:
Cancer Discovery. :OF1-OF20
The BCL2 inhibitor venetoclax (VEN) in combination with azacitidine (5-AZA) is currently transforming acute myeloid leukemia (AML) therapy. However, there is a lack of clinically relevant biomarkers that predict response to 5-AZA/VEN. Here, we integr
Autor:
Andreas Trumpp, Tim Sauer, Carsten Müller-Tidow, Simon Raffel, Michael Heuser, Caroline Pabst, Michael Hundemer, Christoph Röllig, Richard F. Schlenk, Lisa Vierbaum, Stefanie Gryzik, Susanna Grabowski, Julia M. Unglaub, Vera Thiel, Darja Karpova, Elisa Donato, Rabia Shahswar, Maike Janssen, Barbara Betz, Cecilia Reyneri, Karolin Stumpf, Simon Renders, Aino-Maija Leppä, Alexander Waclawiczek
Transcriptomic and functional characterization of LSC-like cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92fdf3e350e2aadcebfc55b01e017a79
https://doi.org/10.1158/2159-8290.22787566
https://doi.org/10.1158/2159-8290.22787566
Autor:
Andreas Trumpp, Tim Sauer, Carsten Müller-Tidow, Simon Raffel, Michael Heuser, Caroline Pabst, Michael Hundemer, Christoph Röllig, Richard F. Schlenk, Lisa Vierbaum, Stefanie Gryzik, Susanna Grabowski, Julia M. Unglaub, Vera Thiel, Darja Karpova, Elisa Donato, Rabia Shahswar, Maike Janssen, Barbara Betz, Cecilia Reyneri, Karolin Stumpf, Simon Renders, Aino-Maija Leppä, Alexander Waclawiczek
Cell line sensitivity and additional patient data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9e8aa14e3b6fea50beb01f202ffff9
https://doi.org/10.1158/2159-8290.22787569
https://doi.org/10.1158/2159-8290.22787569
Autor:
Andreas Trumpp, Tim Sauer, Carsten Müller-Tidow, Simon Raffel, Michael Heuser, Caroline Pabst, Michael Hundemer, Christoph Röllig, Richard F. Schlenk, Lisa Vierbaum, Stefanie Gryzik, Susanna Grabowski, Julia M. Unglaub, Vera Thiel, Darja Karpova, Elisa Donato, Rabia Shahswar, Maike Janssen, Barbara Betz, Cecilia Reyneri, Karolin Stumpf, Simon Renders, Aino-Maija Leppä, Alexander Waclawiczek
Comparison of MAC-Score and BH-3 profiling based response prediction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ea2692e0a3c2496dabe399088fb775
https://doi.org/10.1158/2159-8290.22787548
https://doi.org/10.1158/2159-8290.22787548
Autor:
Andreas Trumpp, Tim Sauer, Carsten Müller-Tidow, Simon Raffel, Michael Heuser, Caroline Pabst, Michael Hundemer, Christoph Röllig, Richard F. Schlenk, Lisa Vierbaum, Stefanie Gryzik, Susanna Grabowski, Julia M. Unglaub, Vera Thiel, Darja Karpova, Elisa Donato, Rabia Shahswar, Maike Janssen, Barbara Betz, Cecilia Reyneri, Karolin Stumpf, Simon Renders, Aino-Maija Leppä, Alexander Waclawiczek
MAC-Score predict response within mutational subgroups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c16e236f8dd13f3688b62b47ea7c6c19
https://doi.org/10.1158/2159-8290.22787554
https://doi.org/10.1158/2159-8290.22787554
Autor:
Andreas Trumpp, Tim Sauer, Carsten Müller-Tidow, Simon Raffel, Michael Heuser, Caroline Pabst, Michael Hundemer, Christoph Röllig, Richard F. Schlenk, Lisa Vierbaum, Stefanie Gryzik, Susanna Grabowski, Julia M. Unglaub, Vera Thiel, Darja Karpova, Elisa Donato, Rabia Shahswar, Maike Janssen, Barbara Betz, Cecilia Reyneri, Karolin Stumpf, Simon Renders, Aino-Maija Leppä, Alexander Waclawiczek
The BCL2 inhibitor venetoclax (VEN) in combination with azacitidine (5-AZA) is currently transforming acute myeloid leukemia (AML) therapy. However, there is a lack of clinically relevant biomarkers that predict response to 5-AZA/VEN. Here, we integr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e60368bef9c8c1d25cda8992603243d
https://doi.org/10.1158/2159-8290.c.6637747
https://doi.org/10.1158/2159-8290.c.6637747